Loader

Invitrogen CD62L (L-Selectin) Monoclonal Antibody (MEL-14), Super Bright 702, 25 µg, eBioscience™

On demand
Order number : 67-0621-80
(Ex-work price)
$ On demand

Invitrogen CD62L (L-Selectin) Monoclonal Antibody (MEL-14), Super Bright 702, 25 µg, eBioscience™


The MEL-14 monoclonal antibody reacts with mouse CD62L, a 76 kDa member of the selectin family. CD62L is expressed by neutrophils, monocytes, and subsets of T, B, and NK cells and binds a number of glycosylated, fucosylated, sulfated sialylated glycoproteins including CD34, glycam-1 and MAdCam-1. These interactions mediate rolling of lymphocytes on activated endothelium at the sites of inflammation and homing of cells to the high endothelial venules (HEV) of peripheral lymphoid tissues.


Features

  • Super Bright 702 is a tandem dye that can be excited with the violet laser line (405 nm) and emits at 702 nm. We recommend using a 710/50 bandpass filter. Please make sure that your instrument is capable of detecting this fluorochrome.
  • When using two or more Super Bright dye-conjugated antibodies in a staining panel, it is recommended to use Super Bright Complete Staining Buffer to minimize any non-specific polymer interactions. Please refer to the datasheet for Super Bright Staining Buffer for more information.
  • Light sensitivity: This tandem dye is sensitive to photo-induced oxidation. Please protect this vial and stained samples from light.
  • Fixation: Samples can be stored in IC Fixation Buffer (100 µL of cell sample + 100 µL of IC Fixation Buffer) or 1-step Fix/Lyse Solution for up to 3 days in the dark at 4°C with minimal impact on brightness and FRET efficiency/compensation. Some generalizations regarding fluorophore performance after fixation can be made, but clone specific performance should be determined empirically.
  • Excitation: 405 nm; Emission: 702 nm; Laser: Violet Laser.
  • Recommended Isotype Control: Rat IgG2a kappa Isotype Control (eBR2a), Super Bright 702, eBioscience™.
More  

There are no specifications

There are no report


You May Also Like